title: Cisapride in the treatment of visual hallucinations caused by vision loss: the Charles Bonnet syndrome.
abstract: The authors describe the use of cisapride (Propulsid), a potent 5-HT(3) antagonist, in the treatment of visual hallucinations in two patients with vision loss (the Charles Bonnet syndrome).
authors.affiliation: Department of Psychiatry and Human Behavior, Jefferson Medical College,Wills Eye Hospital, Philadelphia, PA, USA.
authors.forename: N G
authors.initials: NG
authors.lastname: Ranen
authors.forename: R E
authors.initials: RE
authors.lastname: Pasternak
authors.forename: B W
authors.initials: BW
authors.lastname: Rovner
mesh_terms: D000368:Aged; D020117:Cisapride / Q000627:therapeutic use*; D005260:Female; D006212:Hallucinations / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008297:Male; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use*; D013577:Syndrome; D015354:Vision, Low / Q000150:complications*; D014796:Visual Perception
chemical_list: D017366:Serotonin Receptor Agonists; D020117:Cisapride